David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Jack Alan Reynolds
Learn more about PhilPapers
Journal of Medicine and Philosophy 30 (6):663 – 690 (2005)
I perform two analyses of the relationship across diseases between pharmaceutical innovation and the burden of disease in developed and developing countries. Both analyses indicate that the amount of pharmaceutical innovation is positively related to the burden of disease in developed countries but not to the burden of disease in developing countries. The most plausible explanation for the lack of a relationship between the burden of disease in developing countries and the amount of pharmaceutical innovation is that incentives for firms to develop medicines for diseases primarily afflicting people in developing countries have been weak or nonexistent.
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
Similar books and articles
Loke Min Foo (2007). Third Way CR and Third World CR. International Corporate Responsibility Series 3:35-53.
Sofia Lombera & Judy Illes (2009). The International Dimensions of Neuroethics. Developing World Bioethics 9 (2):57-64.
G. J. Rossouw (1994). Business Ethics in Developing Countries. Business Ethics Quarterly 4 (1):43-51.
Morgan P. Miles, Linda S. Munilla & Jeffrey G. Covin (2002). The Constant Gardener Revisited: The Effect Ofsocial Blackmail on the Marketing Concept,Innovation, and Entrepreneurship. [REVIEW] Journal of Business Ethics 41 (3):287 - 295.
Iain Brassington (2012). What's Wrong with the Brain Drain (?). Developing World Bioethics 12 (3):113-120.
Xinqing Zhang, Kenji Matsui, Benjamin Krohmal, Alaa Zeid, Vasantha Muthuswamy, Young Koo, Yoshikuni Kita & Reidar K. Lie (2010). Attitudes Towards Transfers of Human Tissue Samples Across Borders: An International Survey of Researchers and Policy Makers in Five Countries. BMC Medical Ethics 11 (1):16-.
Jorn Sonderholm (2009). In Defence of Priority Review Vouchers. Bioethics 23 (7):413-420.
Michael J. Selgelid (2008). A Full-Pull Program for the Provision of Pharmaceuticals: Practical Issues. Public Health Ethics 1 (2):134-145.
Meri Koivusalo (2010). Common Health Policy Interests and the Shaping of Global Pharmaceutical Policies. Ethics and International Affairs 24 (4):395-414.
Anji Wall (2011). The Context of Ethical Problems in Medical Volunteer Work. HEC Forum 23 (2):79-90.
Added to index2009-01-28
Total downloads7 ( #147,617 of 1,018,111 )
Recent downloads (6 months)1 ( #65,012 of 1,018,111 )
How can I increase my downloads?